Variational AI@VariationalAI
Nov 5
Peter Guzzo and Valentin Beuchillot will be heading to #BIOEurope in Cologne next week. Still a few openings left on the calendar! Reach out on the partnering platform or bd@variational.ai hubs.ly/Q04D1lw_0 #AIDD #AIDrugDiscovery #AIinPharma #GenAIinPharma #DrugDiscovery
0
0
0
13
Variational AI@VariationalAI
Nov 3
Designing brain-penetrant ATR inhibitor is a hard problem; screening might not be the right way to solve it. Rakovina’s kt-5000AI program, built on Enki™, gets a live walkthrough Nov 5, 9:30 a.m. PT. #DrugDiscovery hubs.ly/Q04D3mQY0
0
0
0
12
Variational AI@VariationalAI
Oct 30
Next week Handol Kim and Valentin Beuchillot are at Invest in BC 2026, hosted by Life Sciences BC and presented by Lumira Ventures, during Life Sciences Investment Week. Come meet with us!
#DrugDiscovery #GenerativeAI #AIDD #Biotech #VariationalAI #InvestInBC
0
0
0
19
Variational AI@VariationalAI
Oct 28
We are in Seoul this week for BIOPLUS-INTERPHEX KOREA, with Canada as Country of Honour 🇰🇷 🇨🇦 Come find us at the Canadian Pavilion, or reach out at bd@variational.ai
📍 COEX, Seoul
🗓 October 28 to 30
#DrugDiscovery #GenerativeAI #AIDD #SmallMolecules #VariationalAI #BIX2026
0
0
0
21
Variational AI@VariationalAI
Oct 22
Eight ATR inhibitors have entered the clinic. None is brain-penetrant. @rakovina_rkv designed kt-5000 with Enki™ to meet that profile: 122 compounds, ~2 years, ~US$1M direct external spend to candidate-ready. Full case study: hubs.ly/Q04B-nd00
#AIDD #DrugDiscovery
0
1
1
27
Variational AI@VariationalAI
Oct 20
SK Life Science Labs selects our Enki™ platform for generative AI-driven lead discovery. We will deliver new lead series for an undisclosed SK LSL program: “a faster path to promising leads for challenging targets,” says CSO Ryan Kruger. #AIDD
hubs.ly/Q04BG7fj0
0
0
0
11
Variational AI@VariationalAI
Oct 15
We’re in Seoul for BIX 2026 with the Canadian delegation, taking partnering meetings on AI-enabled lead generation and optimization all three days. Our CEO Handol Kim also moderates the Oct 30 panel on real value in AI drug discovery. #AIDD #DrugDiscovery hubs.ly/Q04BdqTr0
0
0
0
13
Variational AI@VariationalAI
Oct 8
Canada produces strong AI research. Turning it into Canadian #DrugDiscovery companies is the harder part. @S49Research publishes its AI for drug discovery report today, with input from our CEO Handol Kim. #GenerativeAI #AIDD hubs.ly/Q04zyMMm0
1
0
0
18
Variational AI@VariationalAI
Oct 6
Don't miss our CEO, Handol Kim, on BC Tech's Scaleup Academy panel "BC's HealthTech AI Advantage" this Wednesday, Oct 7, 11am PT, online.
hubs.ly/Q04zbLtr0
0
0
0
6
Variational AI@VariationalAI
Sep 30
Come meet with @VariationalAI this week at Discovery on Target Boston! Valentin Beuchillot and Peter Guzzo present the poster C099: novel PRMT6 inhibitors via AI-driven design and synthesis. #AIDD #DrugDiscovery #BostonDOT
hubs.ly/Q04yM8Lx0
1
0
0
21
Variational AI@VariationalAI
Sep 24
Canada isn't short on AI research 🇨🇦 Thank you, @wearebctech for naming Variational AI a 2026 Technology Impact Awards finalist: Gamechanger - AI and Company of the Year - Growth. 📍Join the Gala on Oct 29, at Parq Vancouver.
hubs.ly/Q04ydY-80
#2026TIAs #AIDD #GenAI #AI
0
0
0
15
Variational AI@VariationalAI
Sep 22
Hard targets get easier with better starting chemistry! Next week at Discovery on Target Boston (Sept 28-Oct 1), Peter Guzzo presents poster C099: novel PRMT6 inhibitors via AI-driven design and synthesis. #AIDD #DrugDiscovery #BostonDOT
hubs.ly/Q04xZ-Wd0
0
0
0
13
Variational AI@VariationalAI
Sep 17
#ALLIN2026 wrapped in Montréal 🇨🇦

Thanks to @ScaleAICanada for the great organization and for bringing the AI Canadian community together!

#GenerativeAI #AI #GenAI #VariationalAI
0
0
0
18
Variational AI@VariationalAI
Sep 15
Replying to @VariationalAI
@VariationalAI on the road! Our Co-Founder & CEO is traveling to two Canadian stages next week. @BIOTECanada #BIONATION2026 in Ottawa on Sept. 22 and the @Bioalberta #HLSS2026 in Calgary on Sept 24. 🇨🇦 #AIDD hubs.ly/Q04xsXxW0 #AIDrugDiscovery #GenAIinPharma
0
0
0
12
Variational AI@VariationalAI
Sep 10
At #BostonDOT, Peter Guzzo, our EVP of Drug Discovery, will present a new poster: "Initial Efforts to Discover Novel PRMT6 Inhibitors via AI-Driven Design and Synthesis" detailing the work of our collaboration with @AgoraOpenSci and @EnamineLtd #AIDD
hubs.ly/Q04w_0mZ0
0
0
1
15
Variational AI@VariationalAI
Sep 8
Variational AI is in Montréal next week for ALL IN 2026, Sept 16 and 17. Send us a meeting request on the event app to talk #GenerativeAI in early-stage #DrugDiscovery. Our CEO Handol Kim is also on the Thursday plenary panel, Forum Stage, 3pm ET.
hubs.ly/Q04wYT9T0
0
0
0
10
Variational AI@VariationalAI
Sep 1
Canada builds world-class AI companies. Scaling them globally is rarely a technology problem. Our CEO Handol Kim joins the ALL IN plenary on building Canadian AI champions. Forum Stage, Thu Sept 17, 3pm ET, Montreal. #GenerativeAI #Biotech hubs.ly/Q04w6C470
0
0
0
49
Variational AI@VariationalAI
Jul 16
Our CEO Handol Kim joins the first episode of The Future of Life Sciences series, presented by Merck Canada, on how #GenerativeAI like Enki™ is reshaping #DrugDiscovery in Canada. Watch 🔗 hubs.ly/Q04pH7Bz0 #AIDD #AIinPharma
0
0
1
19
Variational AI@VariationalAI
Jul 14
Honoured to be a @CQDM_Canada Success Story. They bridged us to Merck — and that collaboration validated Enki™ on a genuinely hard #DrugDiscovery problem. Grateful for their role in Canadian #biotech. 🔗 hubs.ly/Q04plvNt0 #AIDD
0
0
0
33
Variational AI@VariationalAI
Jul 9
Tomorrow, our Co-Founder & CTO Jason Rolfe keynotes at UBC on how foundation models are reshaping #DrugDiscovery.
📍Gordon B. Shrum Bldg
🗓July 10, 12pm PDT.
hubs.ly/Q04n-_PB0
All welcome, no registration. #AIDD #GenerativeAI
0
0
0
18
Load more